Cost-Effectiveness of Conjugate Pneumococcal Vaccination In Croatia

The objective of this study is to estimate the potential effectiveness and cost-effectiveness of vaccinating infants with the pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) compared to the 13-valent pneumococcal conjugate vaccine (PCV-13) in Croatia. These vaccines are currently available only for risk groups and on private market with a limited uptake, representing less than 10% of annual birth cohort.

Source: Value in Health - October 23, 2015 Category: Global & Universal Authors: G Bencina, N Van de Velde Source Type: research